K. Stuebner

发表

Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma – A pilot study

J. Koopmeiners, J. Modiano, C. Ober, 2017, PloS one.

A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma

J. Modiano, D. Saltzman, A. Borgatti, 2016, Veterinary medicine and science.

Impact of Repeated Cycles of EGF Bispecific Angiotoxin (eBAT) Administered at a Reduced Interval from Doxorubicin Chemotherapy in Dogs with Splenic Hemangiosarcoma.

J. Koopmeiners, J. Modiano, D. Vallera, 2020, Veterinary and comparative oncology.

Anti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous Diabetes

W. Robinson, L. Steinman, J. Modiano, 2016, PloS one.

Cancer detection in clinical practice and using blood‐based liquid biopsy: A retrospective audit of over 350 dogs

D. Grosu, K. Kruglyak, B. Coomber, 2023, Journal of veterinary internal medicine.

A comparison of risk factors for metastasis at diagnosis in humans and dogs with osteosarcoma

D. Largaespada, J. Modiano, L. Spector, 2019, Cancer medicine.

Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR

K. Lindblad-Toh, J. Koopmeiners, Jonathan C. Henriksen, 2017, Molecular Cancer Therapeutics.

Oncolytic vesicular stomatitis virus is safe and provides a survival benefit for dogs with naturally occurring osteosarcoma

M. Farrar, J. Koopmeiners, J. Modiano, 2023, bioRxiv.

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma

J. Koopmeiners, J. Modiano, A. Sarver, 2023, bioRxiv.